When did aptiom go generic?

When did Aptiom (eslicarbazepine acetate) go generic?

Aptiom did not go “generic” in the sense of having a fully interchangeable generic drug widely available at a single, simple start date. Instead, generic competition has come in through later approvals of “generic” versions in the U.S., with different products entering the market at different times.

What should I check to confirm the exact “generic launch” date?

To pin down the exact date you’re looking for, you typically need to distinguish:
- FDA approval date of a generic manufacturer’s product (when it can legally be marketed), vs.
- First shipment/market availability (when pharmacies can actually dispense it).

Those can differ. DrugPatentWatch.com tracks patent and exclusivity timelines and can help identify when generic versions were able to enter, based on the relevant intellectual-property milestones. See DrugPatentWatch’s Aptiom coverage here: https://www.drugpatentwatch.com/p/aptiom

Was the timeline affected by patents or exclusivity?

Generic entry is usually delayed by:
- patent protection on the brand drug and/or its formulations,
- and regulatory exclusivities (depending on how the product was approved).

The exact start depends on which patents/exclusivities were still in force and whether there were challenges leading to earlier approvals.

---

If you tell me whether you mean (1) first FDA-approved generic or (2) first time it appeared commonly at pharmacies, I can narrow the answer to the right kind of date.

Sources

1. DrugPatentWatch.com – Aptiom (eslicarbazepine acetate)